LGR5 marks targetable tumor-initiating cells in mouse liver cancer
Cancer stem cells (CSCs) are thought to be the main drivers for disease progression and treatment resistance in liver cancer. This study identifies the LGR5+ compartment as an important CSC population, representing a viable therapeutic target for combating liver cancer.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/71ee0de1c34f4f6fa934afafed4f5a27 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|